Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial

Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T13:13:55.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A sitewide NIH notice appears above the error page, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T14:33:39.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label on the 403 Forbidden page changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:11:20.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:50:47.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now displayed on the page. Legacy study-record metadata and navigation text have been removed, representing an administrative cleanup of older content.
    Difference
    17%
    Check dated 2026-09-21T22:14:08.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The site revision label was updated to Revision: v3.6.6, indicating an underlying platform update. There are no changes to the displayed study details or related content.
    Difference
    0.1%
    Check dated 2026-08-31T16:49:36.000Z thumbnail image

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.